Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Week In Review: Osaka Enters $445 Million Deal For Two Hearing Loss Candidates From France's Cilcare By: TalkMarkets June 15, 2024 at 14:40 PM EDT Shionogi, an Osaka innovative pharma, has signed an option agreement with Cilcare of France to in-license two drug candidates aimed at hearing loss in a deal worth up to $445 million. Meanwhile, XtalPi raised $126.8 million in a Hong Kong IPO. Read More >> Related Stocks: Ascentage Pharma Group Beigene Ltd ADR Kyowa Hakko Kogyo Co. Ltd Shionogi & Co. Ltd Takeda Pharmaceutical Ltd ADR Zymeworks Inc Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Week In Review: Osaka Enters $445 Million Deal For Two Hearing Loss Candidates From France's Cilcare By: TalkMarkets June 15, 2024 at 14:40 PM EDT Shionogi, an Osaka innovative pharma, has signed an option agreement with Cilcare of France to in-license two drug candidates aimed at hearing loss in a deal worth up to $445 million. Meanwhile, XtalPi raised $126.8 million in a Hong Kong IPO. Read More >> Related Stocks: Ascentage Pharma Group Beigene Ltd ADR Kyowa Hakko Kogyo Co. Ltd Shionogi & Co. Ltd Takeda Pharmaceutical Ltd ADR Zymeworks Inc
